Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer: A Phase II Trial

NCT07241273 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT07241273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07241273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer: A Phase II Trial
Lead sponsor
UNICANCER
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
September 30, 2031
Enrollment
128 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck, head and neck cancer, head and neck cancers, oropharyngeal cancers, oropharyngeal carcinoma, oropharyngeal squamous cell carcinoma